| :: atorvastatin clinical data |
The available data on atorvastatin and metabolite PK indicate linear based on a full application with regard to clinical efficacy/safety data, no further such data
The effectiveness of simvastatin compared to atorvastatin - a feasibility study A considerable amount of the data needed in clinical studies is increasingly
Atorvastatin Diabetes Study [CARDS]). Allocation: concealed.*. Blinding: blinded (clinicians, patients, pharmacists, data collectors, outcome
Effect on the Lens: Current long-term data from clinical trials do not indicate an adverse effect of atorvastatin on the human lens. Effect on Ubiquinone (CoQ10)
atorvastatin Pfizer clinical data (Alzheimer disease).(Lipitor)(Brief Article) - Find R & D Focus Drug News articles.
Atorvastatin (trade name Lipitor), is a member of the drug class known . Clinical data suggest a greater degree of LDL-lowering at any dose of
The government responded by asking the drug companies to examine their pre- marketing clinical data relating to statin and ALS. The FDA also
Clinical data suggest a greater degree of LDL-lowering at any dose of atorvastatin in the elderly population compared to younger adults (see
Torcetrapib/Atorvastatin Clinical Trial Program is the Largest Ever Conducted by in Studies Underway Around the World * Pfizer Clinician: 'First Data to Show.
I have little doubt in the accuracy of the hypotheses, the design, and the acquisition of the trial data. The effect of atorvastatin on the primary endpoint was
The ClinicalTrials.gov trial registry, launched more than a decade ago, currently against chemical structures and their associated clinical data in the public domain. as 'atorvastatin', which later became known by the trade name Lipitor® .
Pfizer Updates Preliminary Results of Torcetrapib/Atorvastatin Clinical Trials as Abstract for Phase 3 Study is Released size, and preliminary data at this stage may not represent the final results when Phase 3 is completed."
A total of 469 patients were randomised, and efficacy data were obtained from 465 patients, 232 in the rosuvastatin group and 233 in the atorvastatin group
were seen with rosuvastatin versus milligram-equivalent atorvastatin doses ( analysis of variance with with a paucity of data from controlled trials in hypercho- lesterolemic ber 2003 at 76 academic and clinical research centers in the
New data confirms safety of Lipitor in combination with anti blood-clotting drug been supported through an extensive clinical trial program, the Atorvastatin
Over 12 months, new gadolinium-enhancing lesions and/or clinical relapses present preliminary data on a trial combining interferon beta with atorvastatin in
ORLANDO, Florida (Reuters) - Pfizer Inc's Lipitor and AstraZeneca's patients, according to data from a clinical trial presented on Tuesday.
The atorvastatin group did better in tests of cognitive function Other newly published clinical data, this from the interrupted testing of Elan's Aβ
We tested the hypothesis that short-term treatment with atorvastatin improves lung Despite preliminary data showing an absence of clinical benefit with
Data Sources. The probability of a patient achieving a 35%. LDL reduction while receiving sevelamer and atorvastatin was obtained from clinical trial data.
ClinicalTrials.gov Identifier: NCT00529542. Purpose. The purpose of this study is to determine the efficacy of Lipitor (Atorvastatin) for the
Primary Medical Role: Lipitor®(atorvastatin calcium) is a synthetic lipid- lowering agent used to reduce cholesterol. Role in Alzheimer's Disease: A multi-center
In patients with clinically evident coronary heart disease, LIPITOR is indicated to: .. Data from a drug-drug interaction study involving 10 mg of amlodipine and
In patients with clinically evident coronary heart disease, LIPITOR is indi- Pediatric: Pharmacokinetic data in the pediatric population are not available.
atorvastatin dosing lipitor cholesterol medicine atorvastatin calcium atorvastatin clinical data atorvastatin mode lipitor atorvastatin calcium name
HDL-C increases vs atorvastatin in hypercholesterolemic patients with CHD, 10- year CHD risk score >20% (CHD risk equivalent), or clinical evidence of
These data suggest that atorvastatin is more effective than current simvastatin- based . Compliance is a significant factor in clinical practice especially in
metabolites.[14] In addition, clinical studies and in vitro data have suggested an important role for atorvastatin lactone in relation to development of drug-related
atorvastatin Pfizer clinical data (phase III) (hyperlipidemia).(Brief Article) - Find R & D Focus Drug News articles.
In conclusion, while data generated in whole cells indicated that atorvastatin significantly impairs signalling by both the hIP and mP, the in vivo clinical data
Clinical data suggest a greater degree of LDL-lowering at any dose of atorvastatin in the elderly population compared to younger adults (see PRECAUTIONS
Boehringer Ingelheim launches 'Lean-to-Clinic' program for fast drug announced it has submitted pediatric data for Lipitor® (atorvastatin) to
There are few clinical data on the benefits of reducing LDL-C, particularly with was designed to evaluate the clinical effect of high-dose atorvastatin initiated
Ezetimibe with simvastatin more efficacious than atorvastatin as approval of INEGY is based on extensive clinical data that has shown INEGY
Combining it with atorvastatin, a safe and effective statin,3 will provide the needed control of LDL cholesterol. Early clinical data from a phase 2
Clinical data were well-balanced between both groups. Atorvastatin reduced total and low-density lipoprotein cholesterol and PGE2 plasma
TNT was a study of high- versus low-dose atorvastatin in patients with stable The letter states that the clinical data and peer-reviewed
Data given as % change represent % difference relative to atorvastatin alone (i.e. , 0% = no change). # See Sections 5.1 and 7 for clinical significance. * Greater
Data given as % change represent % difference relative to Atorvastatin alone (i.e. , 0% = no change). #See Sections 5.1 and 7 for clinical significance. * Greater
Athens, Greece - Building on existing data, two new studies presented at the head of international clinical and medical research for atorvastatin, Parke-Davis.
Clinical Data: Pitavastatin is a novel statin that induces plaque regression One of these studies demonstrated that pitavastatin was non-inferior to atorvastatin
Most data presented here refer to commercially available statins (atorvastatin, fluvastatin, lovastatin and simvastatin), although statins that have recently been
In an analysis of pooled data from 50 clinical trials including nearly 6000 patients 7: Rare cases of rhabdomyolysis have been reported with LIPITOR and other
Clinical data suggest a greater degree of LDL-lowering at any dose of atorvastatin in the elderly population compared to younger adults (see PRECAUTIONS,
Other Lipid-Modifying Data. See results across other lipid parameters when ZETIA was added to rosuvastatin or atorvastatin.1,2,4. Compare lipid parameters
Atorvastain (Lipitor) was the second best selling human medicine in 2003 There is some early clinical data to show atorvastatin benefit in
They found that pretreatment with atorvastatin and simvastatin It would appear, based on all the clinical data available to date, that there is no
treatment reduced but did not normalize them. In addi- tion, atorvastatin reduced renal lipid content. These data are in agreement with experimental and clinical
This data reiterated previously published dose to dose comparisons. Table 2: Statin Table 5: Clinically relevant statin drug interactions. While rosuvastatin is
Rosuvastatin was more effective and less costly than atorvastatin and at CHD risk and total mortality.3-15 More recently, clinical data demonstrated that more
Less than 2% of patients were discontinued from clinical trials due to adverse events attributed to atorvastatin. Based on data from clinical studies and extensive
Primary prevention of cardiovascular disease with atorvastatin in type 2 blinded (clinicians, patients, pharmacists, data collectors, outcome assessors,
Due to insufficient data, the manufacturer does not recommend ezetimibe for patients who cannot tolerate a statin or cannot be controlled on a high dose statin.
Article: Outcomes of Using High- or Low-Dose Atorvastatin in Patients 65 Years analysis and interpretation of the data, drafting of the article, clinical revision of
This study assessed the cost-effectiveness of atorvastatin 10mg, compared with no treatment, The clinical data were selected by the authors.
Atorvastatin reduces the expression of aldo-keto reductases in HUVEC and PTEC. inhibitor therapy and stroke risk reduction: an analysis of clinical trials data.
Sulindac, atorvastatin, or prebiotic dietary fiber may reduce colorectal cancer ( CRC) risk. However, clinical trial data are currently limited.
potent than atorvastatin, simvastatin, and pravastatin. There are no long-term safety data or clinical compared rosuvastatin with atorvastatin, one of which
Recent clinical data support that treatment of hypertensive patients effects, the effect of atorvastatin alone or in combination with amlodipine was analyzed in
At the time of study initiation, no clinical data were available on the effects of atorvastatin (or statins in general) on BMD; therefore, statistical
recently, clinical data demonstrated that treatment with atorvastatin, rosuvastatin, or simvastatin greater with rosuvastatin versus atorvastatin or simva-
No data exist concerning the potential effects of statin therapy on borderline open clinical trial in Japan, 70 patients with ACS received atorvastatin 20 mg daily
Atorvastatin is the drug of choice for lowering LDL cholesterol levels. . Importantly, a review of the literature and data from various clinical trials
Objective: Our objective was to explore the effects of atorvastatin on changes of CD4+CD25+ regulato. RESULTS. Basic Clinical Data of Patients
DATA SOURCES--Summaries of carcinogenicity studies published in the 1992 and Evidence of carcinogenicity of lipid-lowering drugs from clinical trials in 45%), and no change whatever in the all-cause death rate for atorvastatin (Lipitor ).
Methods: Data were pooled for 21 completed (2502 pa- tients) and 23 ongoing ( 1769 patients) clinical trials of atorvastatin conducted in US and international
Safety Data. Table 2 shows the clinical and laboratory safety profiles for simvastatin and atorvastatin as assessed by the incidence of adverse experiences that
The study is similar to the re-evaluation of the CREDO-data [2] and the Lack of adverse clopidogrel- atorvastatin clinical interaction from
Cumulative clinical trial data on atorvastatin for reducing cardiovascular events: the clinical impact of atorvastatin. Kevin a. Bybee, John h. Lee and James h.
LifeCycle Pharma Announces Positive Data From LCP-AtorFen Phase I Clinical Program MedicalNewsToday - Tue, 27 Feb 2007 08:00 EST; Lipitor may cut
On the basis of this information, the MHRA reviewed clinical trial data, cases reported after marketing and literature on the use of statins with occurrences of the
Other MRI-based parameters as well as changes in clinical scores and Our data suggest that high-dose atorvastatin treatment in RRMS is safe and well
During the last decade clinical data on the benefits of statins in the prevention of cardiovascular disease have accumulated [1]. Statin consumption, measured as
online us pharmacy Atorvastatin can i atorvastatin clinical data with free dr consultation cheap Atorvastatin overnight delivery cod shipping
When he saw the first clinical data on Lipitor, that was the first “WOW!” moment he experienced. That was in 1990. He had originally begun working on the drug
Despite the presence of numerous clinical studies, data on atorvastatin related to primary prevention are limited compared to secondary prevention. In this article
However, supporting clinical data from human studies are lacking. We hypothesized that atorvastatin might inhibit JNK and dendritic cells, resulting in
treatment periods (data not shown). Safety Data. Table 2 shows the clinical and laboratory safety profiles for simvastatin and atorvastatin as assessed by the
Clinical data were obtained from a pooled analyses of the 3 clinical trials that directly compared high-dose atorvastatin with conventional standard-dose statins
Clinical data The drug combination atorvastatin/amlodipine (trade names Caduet in the US and Australia, and Envacar It is a fixed dose combination drug containing the calcium channel blocker amlodipine and the statin atorvastatin.
Lowering LDL-C: Switching Therapy Comparative Data · > in the ECLIPSE trial, CRESTOR helped more patients achieve LDL-C goals than Lipitor. Although the clinical significance of this finding is unknown, dose reduction should be
There are no good data to support greater safety with one particular statin Heart, Lung, Blood Institute (ACC/AHA/NHLBI) released a clinical advisory of the
Clinical Data. Baseline clinical characteristics were well balanced between both groups (Table 1). Similarly, there were no significant differences in basal levels
The clinical relevance of these data is unclear. Atorvastatin. (10), the interactions of atorvastatin with CsA, verapamil, and is used clinically as a lipid-lowering
Detailed Amlodipine/Atorvastatin dosage information for adults. Clinical data suggest a greater degree of LDL-lowering at any dose of atorvastatin in the
A modelled US analysis that also included data from IDEAL and other based on major clinical trials comparing atorvastatin with placebo,
Overall, coadministered atorvastatin and amlodipine was well tolerated and Presentation of multivariate data for clinical use: the Framingham Study risk
A comprehensive assessment of the clinical trial safety data for atorvastatin seems particularly relevant at this time. In addition, studies have suggested that
LIPITOR can help support many of your high-risk patients with type 2 diabetes or CHD To access a library of clinical study abstracts and reprints, click here
Clinical trial: Pleiotropic Effects of Atorvastatin in High process all participants will fill out a questionnaire with demographic and clinical data.
gle (patient) blind to high dose Atorvastatin 40 mg daily or placebo in addition to . An investigator (MS) blinded to the clinical data or treatment allocations
Atorvastatin clinical data Crestor atorvastatin calcium tablets Orange and lipitor atorvastatin calcium? Atorvastatin Tablet, The research was performed on human
Clinical data suggest a greater degree of LDL-lowering at any dose of drug in the elderly patient population compared to
DESCRIPTION. ATORLIP-EZ is a fixed-dose combination of atorvastatin and ezetimibe . Clinical data suggest a greater degree of LDL-lowering at any dose
People on a high-dose regimen of the cholesterol drug Lipitor may have a This latest study, based on data from three large clinical trials,
However, clinical data were controversial and the potential This study aimed to investigate the effect of atorvastatin on ambulatory BP in
Studies evaluating atorvastatin (i.e., abstracts, clinical trials, proceedings, data on file with the manufacturer) were considered for inclusion.
efficacy and safety of 10 mg atorvastatin in the control of dyslipidaemia in these patients. We carried . Table 1 Demographic and clinical data at baseline. Age†
Atorvastatin are Similar to Recent Human Trial. Data Using Another Statin. Recent human clinical data demonstrated that statin (i.e., Crestor®) therapy reduced
However, without data on future events and the longterm use of medical resources for atorvastatin we were forced to rely on the data from the published clinical
Statin use was also associated with a decrease in cardiovascular We modeled the 4D Study using clinical data abstracted from a large,
Since the 1970s, there have been substantial epidemiological data . the upper limit of normal occurred in < 0.7% of people treated with statins in clinical trials.
Relative LDL-lowering Efficacy of Statin and Statin-based Therapies . This was higher than the labeled risk (based on clinical trial data) of
Import Your Data a lipid (1); active site (1); aspirin (1); atorvastatin (6); autoimmune hepatitis (1) Top matches for clinical trials related to this article and
The analysis was based on clinical outcome data from the MIRACL study. In the atorvastatin group, monitoring costs were also added.
concept trial evaluating atorvastatin for clinical benefit. We used tests of . ance considering last observation carried forward data using base- line observations
In the last 2 years, data has become available on nearly 32000 patients, in clinical These trials show the remarkably consistent clinical benefit of atorvastatin in
Clinical data merely provides a tool for guiding treatment choices, not a bad thing , particularly if ATORVASTATIN going to both of you for the
Atorvastatin calcium is a white to off-white crystalline powder that is insoluble in . Clinical data suggest a greater degree of LDL-lowering at any dose of drug in
Comprehensive assessment of atorvastatin's safety profile using data from 44 clinical trials comprising 16495 patients demonstrated that the incidence of
Clinical Trials - clinicaltrials.gov The present study is assessing the efficacy and safety of AVE5530 (25mg co-administered with all approved doses of atorvastatin in a double-blind comparison with However, clinical data were controver.
Clinical data, Plaque regression, Elderly patients, Post-marketing surveillan. CYP3A4 metabolizes lovastatin, simvastatin and atorvastatin [4].
Atorvastatin: Brands, Medical Use, Clinical Data. Rx drug information, pharmaceutical research, clinical trials, news, and more
In response to the request, the doctor received results of the prerelease clinical evaluation phase of atorvastatin.1 Knowing that the data would
PROVE IT—TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection . Prescribing information data and clinical experience suggest that only a few statins
were similar. The findings for atorvastatin confirm those from a previous subgroup analysis of pooled data from over 20 clinical studies, in which atorvasta-
UKPAR Lipitor 5mg, 10mg, 20mg and 40mg Chewable Tablets. PL 16051/0006- 9. 9. PRE-CLINICAL ASSESSMENT. No new pre-clinical data have been
Therefore, randomized clinical trials are needed to provide better evidence on Data from completed clinical trials suggest that atorvastatin has the potential to
Read about the risks and benefits of LIPITOR® (atorvastatin calcium). And LIPITOR, along with diet, is clinically proven to reduce the risk of heart attack and stroke in patients with heart *Data Warehouse, SDI, January 2002-March 2010.
This is a multi-center, prospective, randomized placebo controlled clinical trial. Target enrollment is 100 women, with 50 receiving atorvastatin and 50 receiving
Clinical outcome trials showing benefits of atorvastatin have been of data from the TNT trial show that patients with previous coronary artery
This article reviews the safety of statins, with emphasis on high-dose atorvastatin (80 mg), the agent with the most efficacy data for clinical outcomes. Although
Clinical trials have demonstrated that statin therapy reduces cardiovascular events and mortality (6)(7). The MIRACL Study demonstrated that atorvastatin
Whether lower atheroma volumes result in better clinical outcomes is also unclear; until more data are available, we have no reason to favor
Effects of High Doses of Simvastatin and Atorvastatin on High-Density at doses expected to produce similar effects on lipids in a large clinical trial (n=842) However, the present data indicate that differences in metabolic effects of
Conclusions: The experimental and clinical trial data with atorvastatin demonstrate a broad database supporting how atorvastatin impacts cardiovascular risk.
The analysis correlates well with thermodynamic studies and clinical data as these point to rosuvastatin (Crestor) and atorvastatin as the best
of pooled data from 49 clinical trials of atorvastatin in 14236 patients treated for an average period of 2 weeks to 52 months was conducted. The study compared
ritonavir, for doses of LIPITOR exceeding 20 mg, appropriate clinical Pediatric: Pharmacokinetic data in the pediatric population are not available. Gender:
Atorvastatin, Generic in 2011 High potency The most clinical event data, including primary and secondary prevention and stroke data Has a CHF indication
Atorvastatin is the active ingredient in the most popular prescription medicine in It has been studied in more than 400 ongoing and completed clinical studies . drugs are available and data are available that compare these to atorvastatin:
Contents. 1 Pharmacology; 2 Clinical trials. 2.1 ENHANCE trial data; 2.2 Subsequent debate and enquiries; 2.3 IMPROVE-IT trial. 3 Advertising campaign; 4
Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque. This study has been completed. First Received on
Lipitor was the fifth statin drug to the market and had limited clinical data compared to the established cholesterol lowering drugs. The early
Learn about the prescription medication Lipitor (Atorvastatin Calcium), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.
In addition, new scientific data shows that when levels of another type of cholesterol, . Although clinical results indicated superior efficacy for Lipitor, the fact
The clinical safety database includes safety data for 249 paediatric patients who received atorvastatin, among which 7 patients were < 6 years old, 14 patients
b Division of Clinical Epidemiology, Royal Victoria Hospital/McGill University Health Center, A concern has been raised that atorvastatin may competitively inhibit the Outpatient prescription data include information on the nature, quantity,
Based on data from clinical studies and extensive post‑marketing experience, the following paragraphs present the adverse event profile for atorvastatin.
The risk of atorvastatin induced myopathy may therefore be increased with concomitant use of fibric acid derivatives. Pre-clinical data suggest that gemfibrozil
Fueled by mounting data outlining the benefits of transcatheter aortic valve implantation (TAVI), an expert Guiding Clinicians Toward Accountability with CDS: 02.22, 2:15-3:15pm · Mylan nets FDA approval to market generic Lipitor
Modulation of CYP3A4-Mediated Atorvastatin Metabolism in Human Liver Microsomes by data revealed AUC changes that were within ± 2-fold of clinical data.
The clinical meaning of our present results must be considered cautiously. The data did not demonstrate that atorvastatin directly influences the production of
These trials show that high-dose statin therapy provides an additional 11% to . Prescribing information data and clinical experience suggest that only a few
ZETIA : Clinical Trial Experience : Other Lipid-Modifying Data Lipid parameters when adding ZETIA to atorvastatin 40 mg vs doubling the dose of atorvastatin
atorvastatin deteriorate atorvastatin clinical data atorvastatin empty stomache atorvastatin fenofibrate atorvastatin effects atorvastatin generic lipitor atorvastatin
efficacy and safety of atorvastatin in patients with mild to moderate AD. . Clinical Data Operations of Pfizer Inc., with blinding of both the
*These data did not include Caduet® (amlodipine besylate/atorvastatin calcium). No LDL-C.10. In clinical trials enrolling patients with comorbid hyper-
However, physicians appear reluctant to use high doses of statins. A retrospective analysis of pooled data from 49 clinical trials of atorvastatin in 14236 patients
A new study is due in 2013, and if the clinical data works against Vytorin, then a Lipitor/Zetia combo may not be as successful in the market as expected.
In patients with clinically evident coronary heart disease, LIPITOR is Clinical data suggest a greater degree of LDL-lowering at any dose of drug in the
Overview of clinical data for ezetimibe + atorvastatin back pdf. Clinical trials of ezetimibe + atorvastatin (atorvastatin, Lipitor) and the meta-analysis of their results
Idenix Announces Removal of the Partial Clinical Hold on HCV Nucleotide .. 3, 2012 /PRNewswire/ -- Tocagen Inc. today announced the publication of data . its Abbreviated New Drug Application (ANDA) for Atorvastatin Calcium Tablets,
Short-term treatment with either rosuvastatin or atorvastatin inhibits pre-clinical or clinical data and enquiries from potential sponsors are
Atorvastatin upregulates regulatory T cells and reduces clinical disease Our data revealed that the suppressive function of Treg from RA
The literature data available on the management of. HAART-related dyslipidemia with pravastatin, atorvastatin or fluvastatin have been limited to few clinical
target population using a well-matched control group. At the time of study initiation, no clinical data were avail- able on the effects of atorvastatin
Dr. Alsheikh-Ali et al. also examined data from thirteen clinical trials for associations between LDL reduction with statins and the risk of cancer. The authors
Overview of clinical data for Atorvastatin back pdf. Clinical trials of Atorvastatin ( atorvastatin, Lipitor) and the meta-analysis of their results are available for the
The implementation of treatment goals for diabetes is challenging, however, and has been suboptimal in most clinical settings.11 Data from the 1999-2000
Overview of clinical data for atorvastatin back pdf. Clinical trials of atorvastatin ( Lipitor) and the meta-analysis of their results are available for the following
SATURN: Maximum doses of rosuvastatin and atorvastatin equally . We have no clinical DATA relating plaque regression by IVUS with
Additional data from clinical trials on longer-term outcomes (cardiovascular rosuvastatin and atorvastatin therapy in a usual care, clinical practice setting.
Other Lipitor Significant Clinical Studies 6.6.1 Lipitor Pre-Clinical Data 6.6.1.1 Atorvastatin Proves to be More Liver Selective Than Pravastatin
pitavastatin Kowa clinical data (phase III)(hyperlipidemia). atorvastatin (10 or 20 mg) once daily, pitavastatin showed comparable efficacy to
While atorvastatin was found to significantly impair signalling by both the hIP and mP in cultured whole cells, the in vivo clinical data indicated
ATORLIP-F is a fixed-dose combination of atorvastatin and fenofibrate . Clinical data suggest a greater degree of LDL-lowering at any dose of drug in the
“attributable to consistent evidence showing the strong clinical benefits of Lipitor.” In various studies, Lipitor “continues to deliver unprecedented clinical data
Clinical research. Hypotensive effect of atorvastatin in hypertensive patients: the association among flow-mediated dilation, oxidative stress and endothelial
In comparative trials, atorvastatin had a similar adverse event profile to that of other HMG-CoA reductase inhibitors. Clinical data with atorvastatin are limited at
Atorvastatin Medication Fraud Is A Generic Card atorvastatin date it goes generic. Data online purchase clinical atorvastatin cheap
Clinical data suggest a greater degree of LDL-lowering at any dose of atorvastatin in the elderly population compared to younger adults (see [#section- 7.14
atorvastatin. Clinical PGx; PGx Research; Overview; Properties; Pathways; Is Related To; Downloads/LinkOuts. Dosing Guidelines Drug Labels Clinical
From the available clinical trial data, atorvastatin can be considered one of the most effective statins, not only by taking into account its effects
Clinical Pharmacologyl Biopharmaceutics Review(s) _ . stability data for Lipitor tablets manufactured at Vega Baja and Freiburg i Should you have any
The term “clinical benefit” derives from the primary TNT manuscript as written analysis and interpretation of the data, drafting of the article, clinical revision of
that the addition of atorvastatin can provide a regular, safe and improved treat- ment in . and clinical data, was compatible with lymphoma, which was clinically
Cumulative clinical trial data on atorvastatin for reducing cardiovascular events: the clinical impact of atorvastatin. Bybee KA, Lee JH, O'Keefe
Atorvastatin: Effective Therapy for a Broad . Atorvastatin Clinical Development. 0. 500 JAMA. 1996;275:128-133, and data on file, Parke-Davis (981-38).
Learn about the risks and benefits of LIPITOR® (atorvastatin calcium). of MI and stroke in patients with type 2 diabetes and without clinically evident CHD, but with multiple risk factors; IMS Transaction Co-Pay Data 8/1/2010 - 1/31/2011.
To apply a mechanistic clinical pharmacokinetic (PK) model to predict concept and enterohepatic recycling was developed to describe atorvastatin and ( deficient OATP1B1 activity) data was fit to determine non-OATP1B1-mediated hepatic
Data given as % change represent % difference relative to atorvastatin alone (i.e. , 0% = no change). †: See Sections 5.1 and 7 for clinical significance. ‡: Greater
Less than 2% of patients were discontinued from clinical trials due to side effects attributed to atorvastatin. Based on data from clinical studies and extensive
(LDL-C≥ 100mg/dL) who were on a stable low dose of atorvastatin (10 mg). . in research and development, future clinical data and analysis,
An extensive series of published clinical data shows the safety and efficacy of Lipitor. * Recently, analyses of the safety of Lipitor over its dose
Plasma concentrations of atorvastatin are higher in healthy elderly subjects than in young adults, and clinical data suggest a greater degree of LDL-lowering at
14] In addition, clinical studies and in vitro data have suggested an important role for atorvastatin lactone in relation to development of
In this retrospective pooled analysis of data from50 completed clinical trials, wc compared the tolcrabil-ity profiles of atorvastatin 10, 20, 40, and 80 mg/d,and
MOH Approved: 28 October 2010. Page 1 of 22. DATA SHEET. LIPITOR® . Clinical studies demonstrate that the starting dose of 10 mg atorvastatin is more
Geriatric: Plasma concentrations of Atorvastatin are higher in healthy elderly subjects (age >/=65 years) than in young adults. Clinical data suggest a greater
Clinical trial data. Evidence is strong for atorvastatin 10mg (ASCOTrLLA, CARDS ) and simvastatin up to 40mg (HPS, 4S) but not for atorvastatin 20mg the only
subjects receiving atorvastatin were at greater risk for either clinical or MRI disease though several mechanisms of action were proposed.4-8 Recent data with
ment careful and deliberate evaluations of statin safety, reaffirming the .. 9. HIGHLIGHTS. • Clinical data suggest that both CRP and LDL-cholesterol are
Key Data. Drug (brand/generic) Lipitor / Torcetrapib; Company/licensee Pfizer Further clinical evaluation of torcetrapib has ceased bringing to an end the
companies became required to develop a new drug filing with sufficient pre- clinical data to support its role as first-line Does Lipitor Cause Acne Does Lipitor
the robust bulk of clinical data obtained from prospective statin studies is lacking for the fibric acid derivatives, and the results of the major trials are equivocal.
The efficacy of higher-potency regimens in clinical practice in patients who have . Although there are published data regarding the efficacy of statin and other
In patients with clinically evident coronary heart disease, LIPITOR is indicated to: .. Clinical data suggest a greater degree of LDL-lowering at any dose of drug
One of the first major clinical trials with Merck's new CETP inhibitor has with atorvastatin (Lipitor, Pfizer) in 589 patients with lipid disorders,
Early phase 2 data on torcetrapib, published in April 2004, showed that in . torcetrapib 60 mg and atorvastatin 10-80 mg is now in phase 3 clinical trials as part
Based on the clinical CARDS data, the favourable cost effectiveness of atorvastatin 10 mg in type 2 diabetes patients has been demonstrated in
Below is a brief commentary on some of the data I found to be the most regarding atorvastatin and clopidogrel interactions into the clinical
Results: A total of 18 637 patients were prescribed atorvastatin (n = 6420), .. Unmeasured comorbidity as well as missing clinical data (e.g.,
Associate Professor of Clinical Pharmacy, College of Pharmacy, Ohio Northern The case presented here suggests a drug interaction with atorvastatin . As with most single case reports, there are limited objective data available in this case;
In conjunction with other clinical data it was concluded that Mr Xs brain function disturbance was due to a cholesterol lowering drug Lipitor. This medication was
Main outcome measure: Association of CYP3A4 metabolised statin and clopidogrel Clinical, demographic, treatment, and outcome data were
rosuvastatin over atorvastatin in clinical practice.7 Findings were from data retrieved. Figure. STELLAR: Percentage of Patients Who Met ATP III Goals at End of
Lipitor tablets for oral administration contain 10, 20, 40, or 80 mg atorvastatin . Clinical data suggest a greater degree of LDL-lowering at any dose of drug in
Clinical Therapeutics, Volume 30, Issue 12, Pages 2298-2313, December 2008, with stable coronary artery disease: Results of the CAP (Comparative Atorvastatin No significant differences in baseline demographic or clinical data were
Data pooled from 21 atorvastatin clinical trials have been analyzed to establish the safety of reducing low density lipoprotein cholesterol (LDL-C) levels below
Table 1 Demographical, clinical and operative data of the patients (n = 40). Characteristics. Atorvastatin pretreatment n = 20 No atorvastatin pretreatment n = 20
"These findings add to the wealth of clinical data that support the impressive efficacy and safety profile of Lipitor across the dose range."
Data from several clinical trials support the use of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statin) and fish oils [rich source of
Based on the clinical CARDS data, the favourable cost effectiveness of atorvastatin 10 mg in patients with type 2 diabetes has been demonstrated in countries
CONCLUSIONS: The experimental and clinical trial data with atorvastatin demonstrate a broad database supporting how atorvastatin impacts cardiovascular
Six of these patients were taking simvastatin which, along with atorvastatin, is fully funded in New dose related; the incidence, determined from clinical trials, is approximately 0.03% at 20mg, 0.08% Lipitor Data Sheet 30 September 2003 .
Although the combination of ezetimibe with a low atorvastatin dosage . Demographic and clinical data were compared between groups using
Few advantages seen for Crestor over Lipitor-study serious consequences or death, according to data from a small mid-stage clinical trial.
Nonclinical Findings and Clinical Relevance in vitro than cerivastatin, fluvastatin, simvastatin and atorvastatin. These data suggest the rosuvastatin is less likely to induce skeletal toxicity in comparison with other statins.
For this purpose, data on hyperlipidemia will be elicited over an Study On Liprimar (Atorvastatin) In Patients With Coronary Heart Disease
The funders had no role in study design, data collection and analysis, . of atorvastatin reduces plasma levels of CRP and clinical disease activity in CD patients
Extended Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome, Statin, Coronary Plaque, Acute Coronary Syndrome
1 We offered no data on how the atorvastatin-clopidogrel drug-drug interaction might influence clinical outcomes. This subject requires additional evaluation.
Joint soreness and pain are potential side effects of taking Lipitor. According to the website eMedTV, based on data from clinical studies, joint pain was seen in
Clinical Data Published in Vaccine Demonstrate Robust Immune Response Lipitor (atorvastatin) did not slow atherosclerosis in children with
Recent clinical trials suggest an LDL-independent superiority of intensive statin .. Our data demonstrates that 80 milligrams of Atorvastatin per day, beginning
Nevertheless, trial data showed that Lipitor reduced LDL cholesterol by And because clinicians believed (and still do) that LDL cholesterol is
Atorvastatin, sold by Pfizer under the trade name Lipitor, is a member of the drug class known as statins, used for lowering blood cholesterol.
We are not aware of any data describing the transfer of atorvastatin or In situations where clinical data in humans are lacking, we can use predictive models to
AZ's Crestor shows no benefit over Lipitor in SATURN trial. AstraZeneca's shares have taken a bashing this morning after data was published
The effects of lipid-lowering therapies were based on clinical trial data. The addition of ezetimibe to atorvastatin therapy was less costly and
This, together with a raft of data demonstrating that lowering AstraZeneca in terms of clinical profile, yet annual sales of Lipitor™ have run at
Abstract Objective:Observation of atorvastatin calcium on curative effect Results: (1) Sets of clinical data, IMT, blood lipids and inflammatory
"The extensive clinical trial data regarding the safety and efficacy of Lipitor has not established a causal link between Lipitor and memory loss
The clinical safety database includes safety data for 249 paediatric patients who received atorvastatin, among which 7 patients were < 6 years
Results: Simvastatin is markedly cheaper than atorvastatin, but evidence suggests This finding highlights the value of clinical data and reflects the conflict that
Reporting System (AERS) data, cohort and clinical trial results, and analysis of the assessment of its 4 Expert Panels, which focused on issues of statin safety
They identified results from four large randomized controlled trials (RCTs) and a large retrospective analysis of pooled data from 49 clinical trials of atorvastatin.
But Pfizer, which plans to use marketing muscle and clinical data to fight that migration, says that Lipitor has unique benefits and is worth a
Pfizer researchers also presented data from a separate study involving 40 patients to "The torcetrapib/atorvastatin clinical program is building on the proven
Plasma levels of atorvastatin and its active and inactive metabolites were metabolites, in turn increasing the risk of clinically important adverse events such as . Data from six sampling times within 24 h after drug intake were used to obtain
Overview of clinical data for atorvastatin high dose back pdf. Clinical trials of atorvastatin high dose (atorvastatin, Lipitor) and the meta-analysis of their results
Preclinical and clinical data on atorvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, indicate that it has superior activity in
The review was thorough, including reports to the FDA and data from clinical trials, In no trial was there a significant difference between statin and placebo
(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol -1-yl]-3,5-dihydroxyheptanoate. Clinical data. Trade names, Lipitor
Cumulative clinical trial data on atorvastatin for reducing cardiovascular events: the clinical impact of atorvastatin. (PMID:18358084). Abstract; Citations List of
*Significantly less than atorvastatin 10 mg (P<0.001). Data on file. Parke-Davis, Morris Plains, NJ. The impact on clinical outcomes of the differences in
treatment of dyslipidemia,1,2 important new clinical data has emerged to atorVastatin Evaluation and Infection Therapy (PROVE-IT)5 studies have shown that
However, patients with atorvastatin-related myopathy had 2.4-fold and 3.1-fold . Table I - Demographics and clinical chemistry data of patients and controls at
ClinicalTrials.gov Identifier: NCT00252967. Purpose. The purpose of this study is to test whether the drug, atorvastatin, will be able to reduce the of abnormal beats, and preliminary data in humans supports an effect of atorvastatin and other
Atorvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A . Clinical data suggest a greater degree of LDL-lowering at any dose of drug in the elderly
Cost-effectiveness analysis of rosuvastatin versus atorvastatin, simvastatin, and The clinical data came from a multi-centre, open-label, prospective,
Find LIPITOR® (atorvastatin calcium) resources and safety info at the Interactive statin therapy, clinicians will benefit from familiarity with these safety data.
6.6.1 Lipitor Pre-Clinical Data. 6.6.1.1 Atorvastatin Proves to be More Liver Selective Than Pravastatin. 6.6.2 Atorvastastin Clinical Data. 6.6.2.1 Atorvastatin Was
Mædica A Journal of Clinical Medicine, Volume 2 No.2 2007. 158 patients. Clinical data demonstrate that atorvastatin 20 mg/day during 8 weeks and a
The atorvastatin clinical trial programme is comprised of an extensive series of studies that will ultimately provide signifi- cant data for the use of statin therapy in
Other Lipitor Significant Clinical Studies. 6.6.1 Lipitor Pre-Clinical Data. 6.6.1.1 Atorvastatin Proves to be More Liver Selective Than Pravastatin
Review LDL-C decrease and LDL-C goal attainment results from clinical trial where LDL-C reductions vs atorvastatin in hypercholesterolemic patients with
Homozygous FH patients display a much more severe clinical phenotype with .. atorvastatin; AUClast, AUCinf, Cmax, Tmax, and t1/2 (if data permitted) of
Overview of clinical data for atorvastatin back · pdf. Clinical trials of atorvastatin ( Lipitor) and the meta-analysis of their results are available for the following
Learn about LIPITOR® (atorvastatin calcium) and lipid lowering data. provide a mean 50% LDL-C reduction with a starting dose in multiple clinical trials.5-11
Cumulative clinical trial data on atorvastatin for reducing cardiovascular events: the clinical impact of atorvastatin. Curr Med Res Opin. 2008 Apr;24(4):1217-29.
effects and clinical endpoint data. Lipid effects. From dosing studies, simvastatin 40mg lowers LDL by 3% more than atorvastatin. 10mg and 4% less than
Atorvastatin was instituted in patients with elevated LDL-cholesterol (LDL-C) Lipids and other clinical data were measured at baseline, after 6
5 statins as mono-therapy and in combination with a non-statin. Summary data from. 21 clinical trials (~10000 patients) were included for LDL-C. Emax models
Research from Hacettepe University Provides New Data about Atorvastatin Basic & Clinical Pharmacology & Toxicology, "HMG-CoA reductase inhibitors
Search results for: atorvastatin . Supp. w / Clinical Data Amlodipine Besylate and Benazepril Hydrochloride Capsules, Mylan Pharmaceuticals Inc,
Rx drug information, pharmaceutical research, clinical trials, news, and more Atorvastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)
Eight studies [5-12] were then excluded due to the prospective crossover design or the lack of data on clinical outcomes. Thus, a total of 7 RCTs were finally
METHODS: Data were pooled for 21 completed (2502 patients) and 23 ongoing ( 1769 patients) clinical trials of atorvastatin conducted in US and international
been investigated. Atorvastatin, ffuvastatin, pravastatin and simvastatin caused a significant These data indicate that HMGCoA reductase inhibitors effect on the arterial .. Several in ®itro and pre-clinical evidence support the hypothesis of a
One hundred patients were randomly assigned to receive 20 mg atorvastatin or .. On the basis of clinical data from this study, there is clear benefit to the use of
Safety data is reported based on pooled data from 21 completed and 23 ongoing clinical trials with 4271 patients on atorvastatin for a total of more than 3000
Name: